News for hackers. Stuff that matters.
Re:FDA declines to review Moderna's mRNA flu shot by icegreentea2 on Tuesday February 10, 2026 @11:58PM (#46971034)
No, they're implying that Moderna should have used a high dose flu vaccine in the >65 age group as the control condition in the efficacy trial.

EDIT: To be clear, I'm pretty sure that's just some pretext.

Re:FDA declines to review Moderna's mRNA flu shot by cosmicgadget on Wednesday February 11, 2026 @12:03AM (#46971066)
Is sandbagging like this normal in getting FDA approvals or did someone at Moderna f this up?
Re:FDA declines to review Moderna's mRNA flu shot by icegreentea2 on Wednesday February 11, 2026 @12:13AM (#46971119)
Trial designs are rarely perfect, and drug companies will try to stack the deck.

That being said, trial designs aren't made in isolation without consultation. Moderna's press release about this (https://feeds.issuerdirect.com/news-release.html?newsid=7346...) indicates that 2024 CDC said that performing an efficacy trial without using the higher dose would likely cause complications for recommending the mRNA vaccine for the >65 age group, but would not impact overall approval.

Re:FDA declines to review Moderna's mRNA flu shot by stouset on Wednesday February 11, 2026 @12:32AM (#46971250)
That was 2024. I wonder what could possibly be different about today, in 2026?
Re:FDA declines to review Moderna's mRNA flu shot by smt88 on Wednesday February 11, 2026 @01:35AM (#46971642)
This is specifically a political attempt by RFK Jr. to stop people from getting mRNA flu vaccines.
Re:FDA declines to review Moderna's mRNA flu shot by carbonatedmilk on Wednesday February 11, 2026 @01:48AM (#46971712)
Context from the CDC guidance from August 2025 (https://www.cdc.gov/mmwr/volumes/74/wr/mm7432a2.htm)

"Except for vaccination for adults aged ≥65 years, ACIP makes no preferential recommendation for a specific vaccine when more than one licensed and recommended vaccine is available. Among adults aged ≥65 years any one of the following higher dose or adjuvanted influenza vaccines is preferentially recommended: HD-IIV3, RIV3, or aIIV3. If none of these three vaccines is available at an opportunity for vaccine administration, any other available age-appropriate influenza vaccine should be used (4,5)"